78 related articles for article (PubMed ID: 12005222)
21. [Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
He S; Huang H
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):526-8. PubMed ID: 10436957
[TBL] [Abstract][Full Text] [Related]
22. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
[TBL] [Abstract][Full Text] [Related]
23. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
24. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
26. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
27. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
Kondo S; Sauder DN
Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
[TBL] [Abstract][Full Text] [Related]
29. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
Groeneveld PH; Kwappenberg KM; Langermans JA; Nibbering PH; Curtis L
Cytokine; 1997 Feb; 9(2):138-42. PubMed ID: 9071565
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
31. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Karakurt DG; Demirsoy U; Corapcioglu F; Oncel S; Karadogan M; Arisoy ES
Pediatr Hematol Oncol; 2014 Aug; 31(5):415-24. PubMed ID: 24499434
[TBL] [Abstract][Full Text] [Related]
32. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
[TBL] [Abstract][Full Text] [Related]
33. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
35. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
36. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice.
Huaux F; Arras M; Vink A; Renauld JC; Lison D
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):137-45. PubMed ID: 10385602
[TBL] [Abstract][Full Text] [Related]
37. Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases.
Spengler U; Zachoval R; Gallati H; Jung MC; Hoffmann R; Riethmüller G; Pape G
Cytokine; 1996 Nov; 8(11):864-72. PubMed ID: 9047083
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
Joyce DA; Steer JH
J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
[TBL] [Abstract][Full Text] [Related]
39. Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer.
Barber MD; Powell JJ; Lynch SF; Gough NJ; Fearon KC; Ross JA
Clin Exp Immunol; 1999 Sep; 117(3):425-9. PubMed ID: 10469042
[TBL] [Abstract][Full Text] [Related]
40. Serum and plasma parameters in clinical evaluation of neutropenic fever.
Südhoff T; Giagounidis A; Karthaus M
Antibiot Chemother (1971); 2000; 50():10-9. PubMed ID: 10874450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
